The Activin/Nodal/TGF-b signaling pathway plays a major role in maintaining mouse epiblast stem cells (EpiSCs). The EpiSC-maintaining medium, which contains Activin A and bFGF, induces differentiation of mouse embryonic stem cells (ESCs) to EpiSCs. Here, we show that Activin A also has an ability to efficiently propagate ESCs without differentiation to EpiSCs when combined with a MEK inhibitor PD0325901. ESCs cultured in Activin+PD retained high-level expression of naive pluripotency-related transcription factors. Genomewide analysis showed that the gene expression profile of ESCs cultured in Activin+PD resembles that of ESCs cultured in 2i. ESCs cultured in Activin+PD also showed features common to the naive pluripotency of ESCs, including the preferential usage of the Oct4 distal enhancer and the selfrenewal response to Wnt pathway activation. Our finding shows a role of Activin/Nodal/ TGF-b signaling in stabilizing self-renewal gene regulatory networks in ESCs.
Introduction
The decision as to whether pluripotent stem cells self-renew or differentiate is regulated by extracellular stimuli. Thus, the understanding of how extracellular stimuli affect cellular events and processes is crucial for developing strategies to control stem cell fates. The effects of extracellular stimuli on cell fates are complicated and context-dependent. Even in pluripotent stem cells, a little difference in their cell state could cause a large difference in the response to extracellular stimuli. Mouse embryonic stem cells (ESCs) can be maintained in a medium containing serum and LIF (Smith et al. 1988; Williams et al. 1988) . ESCs can also be maintained in serum-free culture conditions such as 2i, which contains a MEK inhibitor that inhibits the ERK1/2 MAPK signaling pathway and a GSK3 inhibitor that activates the Wnt signaling pathway (Ying et al. 2008) , both of which are known to promote ESC self-renewal (Burdon et al. 1999; Sato et al. 2004) . The pluripotent stem cells showing these dependencies on extracellular signals are considered to be in the state of naive pluripotency. Human embryonic stem cells (hESCs) and its mouse counterpart, mouse epiblast stem cells (EpiSCs; Brons et al. 2007; Tesar et al. 2007) , show features of a developmentally later stage than the naive pluripotency state, and the conditions for their maintenance are different from those for ESCs. These pluripotent stem cells are called primed pluripotent stem cells and are shown to be maintained efficiently by Activin/Nodal/TGF-b signaling activation and bFGF signaling activation (Brons et al. 2007; Tesar et al. 2007) .
The naive and primed pluripotent stem cells show markedly different responses to various signaling factors and pathways. LIF, which promotes the naive pluripotency state, has no beneficial effect on the primed state (Dah eron et al. 2004; Tesar et al. 2007 ).
Whereas Wnt pathway activation promotes naive pluripotency (Sato et al. 2004; Ying et al. 2008) , it causes mesoderm differentiation in the primed pluripotency state (Sumi et al. 2008 (Sumi et al. , 2013 Tsakiridis et al. 2014) . Although the ERK1/2 MAPK pathway, which is activated by bFGF, is essential for the maintenance of the primed pluripotency state (Greber et al. 2010; G€ oke et al. 2013) , the naive pluripotency state is promoted by its inhibition (Burdon et al. 1999; Ying et al. 2008) .
Activin, Nodal, and TGF-b are also known to have highly context-dependent effects. They activate the same downstream factors, SMAD2/3, which act as transcriptional regulators (Beyer et al. 2013a ). Whereas they are necessary for the maintenance of the primed state (Vallier et al. 2004; James et al. 2005; Brons et al. 2007; Tesar et al. 2007) , they have the activity to induce endoderm from pluripotent stem cells (Gadue et al. 2006) . Activin/Nodal/TGF-b signaling has been considered as a naive pluripotency inhibitory pathway because its inhibition promotes naive pluripotency maintenance (Hassani et al. 2014) . Understanding of these different responses to signaling pathways is important for efficient manipulation of cell fates. Dissection of signaling pathway responses of each pluripotent state is also important for achieving effective culture conditions for desired states of pluripotency, especially those applicable to a broad range of species.
In this study, we analyzed the responses of naive and primed pluripotency states to signaling pathway modulation. Then, we have unexpectedly found that Activin A, when combined with the ERK MAPK pathway inhibitor PD0325901 (PD), can enhance the naive pluripotency transcriptional circuitry and promotes proliferation of ESCs. The ESCs cultured in Activin+PD also showed features of naive pluripotency in several criteria we tested. These findings provide novel insight into the function of Activin/ Nodal/TGF-b signaling in embryonic stem cell selfrenewal networks.
Results

Wnt signaling induces distinct gene expression changes in mouse ESCs and EpiSCs
To gain insight into the roles of signaling pathway activities in different pluripotency states, we first compared gene expression changes induced by the Wnt pathway activation in mouse ESCs and EpiSCs. The Wnt pathway activation by a small-molecule inhibitor of GSK3, CHIR99021, induced the up-regulation of a Wnt pathway target gene Axin2 to a similar extent in ESCs and EpiSCs (Fig. 1A) . Cdx1, another well-known Wnt target gene, was up-regulated by CHIR99021 to a much higher extent in ESCs than in EpiSCs (Fig. 1A) . As previously reported (Tsakiridis et al. 2014) , mesoderm genes, Brachyury and Mesp1, were highly up-regulated by Wnt signaling pathway activation in EpiSCs (Fig. 1A) . Brachyury is known as a Wnt pathway qRT-PCR analysis of gene expression changes. EB3 ESCs and EpiSCs were treated with 3 lM CHIR99021 (CHIR) and 1 lM PD0325901 (PD) for 24 h as indicated. The graph represents mean AE SD (n = 3 independent experiments). (B) Alignments of the mouse genomic sequence near Mesp1 gene and genomic sequences of other species, visualized by VISTA program. The mouse genome (mm10 chr7: 79786839-79798988) was selected as the base genome, and the conservation score between this base genome and genomes of other species is plotted. The conservation score and the regions of high conservation were calculated and visualized using default setting of VISTA program. Regions of high conservation are colored according to the annotation as exons (dark blue), UTRs (light blue), or noncoding (pink). The 3 0 enhancer region conserved among species is enclosed with a red rectangle. (C) Activation of the Mesp1 enhancer by Wnt signaling pathway activation. HEK293T cells were transfected with the reporter vector containing the Mesp1 enhancer region and the expression vector for N-terminal-deleted b-catenin (DN-b-catenin) or an empty expression vector. After 48 h, cells were harvested and luciferase activities were quantified. (D) Global gene expression changes in response to treatment with CHIR and PD in EB3 ESCs (upper left) and EpiLCs (upper right). The GO analysis for those genes that were up-regulated greater than fourfold by CHIR and down-regulated greater than fourfold by PD in EpiLCs is shown target gene (Arnold et al. 2000) . Also, Mesp1 is probably a direct Wnt pathway target gene as its conserved 3 0 enhancer region responded to Wnt pathway activation (Fig. 1B,C) . In ESCs, Wnt pathway activation-induced up-regulation of Brachyury and Mesp1 was very low (Fig. 1A) . The different responses of Wnt target genes in naive and primed states indicate the involvement of additional factors in their expression. In addition to the Wnt signaling pathway, the ERK1/2 MAPK signaling pathway has also been reported to be necessary for mesoderm differentiation (Yao et al. 2003) . Therefore, we were interested in the relationship between these signaling pathways. In EpiSCs, the addition of the ERK1/2 MAPK pathway inhibitor, PD0325901, completely suppressed the Mesp1 up-regulation by CHIR99021 (Fig. 1A) . However, PD0325901 only weakly suppressed Brachyury expression and did not suppress Axin2 or Cdx1 expression (Fig. 1A) , indicating that the sensitivity of Wnt pathway target genes on the ERK1/2 MAPK pathway activity varies among genes.
Next, we examined global gene expression changes induced by Wnt signaling pathway activation in different pluripotency states. A 2-day culture in the EpiSC medium converts ESCs to an epiblastlike state, epiblastlike cells (EpiLCs; Hayashi et al. 2011 ). This short-term induction causes critical changes, which lead to altered signaling responses of the pluripotent cells. We compared the effects of Wnt pathway activation and ERK1/2 MAPK pathway inhibition on the transcriptome in ESCs and EpiLCs. The transcriptome of EpiLCs underwent a greater change than that of ESCs in response to Wnt pathway activation, and an inverse correlation between the responses to Wnt pathway activation and ERK pathway inhibition was observed in EpiLCs ( Fig. 1D ). Ontology analysis showed that those genes that were up-regulated more than fourfold by CHIR99021 and also down-regulated more than fourfold by PD0325901, which contributed to the inverse correlation, were related to several developmental processes including gastrulation (Fig. 1D ). These analyses confirm the ERK dependency of the Wnt-induced differentiation pathway in the primed pluripotency state. We assumed that the different responses to Wnt pathway activation in naive and primed pluripotency states could be at least partly caused by transcription factors that were specifically expressed in the primed state. Then, we overexpressed several transcription factors which were up-regulated by EpiLC induction (Fig. 1E ) and examined the expression levels of a mesoderm gene Mesp1 with or without CHIR99021. The result showed that Otx2 over-expression in ESCs partially changed the mode of response to Wnt pathway activation into that in EpiSCs (Fig. 1E ). This result suggests that Otx2 is one of the signaling response regulators of primed pluripotency. This is in good agreement with previous studies showing the importance of Otx2 as a primed state regulator (Acampora et al. 2013; Buecker et al. 2014; Yang et al. 2014) .
Activin A promotes ESC proliferation and naive pluripotency gene expression when combined with ERK1/2 MAPK pathway inhibition Next, to investigate how other signaling pathways influence the naive and the primed pluripotency state, we conducted gene set enrichment analysis in EB3 ESCs and EpiLCs using the expression profile data from our microarray experiments ( Fig. 2A ). We used published data for the target gene sets of four transcription factors, which mediate important signaling pathways that regulate naive and/or primed pluripotency states (Chen et al. 2008; Marson et al. 2008; Fei et al. 2010; Mullen et al. 2011) . We found enrichment of targets of SMAD3, the transcription factor which is activated under Activin/Nodal/TGFb signaling, in ESCs ( Fig. 2A) . The enrichment of SMAD3 targets in ESCs was unexpected because Activin A has been used to induce EpiSCs from ESCs and Activin/Nodal/TGF-b signaling is considered to be a negative regulator of the naive pluripotency network (Hassani et al. 2014) . The Wnt and BMP4 pathways are both known to be able to promote maintenance of naive pluripotency (Ying et al. 2003; Wray et al. 2011) . The enrichment of SMAD3 targets was stronger than the moderate enrichments of the Wnt pathway effector TCF3 targets and the BMP4 pathway effector SMAD1/5 targets in ESCs, although the enrichment was somewhat weaker than that of STAT3 targets, which is activated by LIF ( Fig. 2A) . These results led us to investigate whether Activin A can promote a naive pluripotency state of ESCs.
We then examined the effect of Activin A on ESC self-renewal under serum-free conditions. After 4-day culture in a serum-free N2B27 medium without additional factors, EB3 ESCs stopped proliferation (Fig. 2B) . Pluripotency genes were down-regulated, showing differentiation of ESCs in the serum-free medium (Fig. 2C) . When Activin A was added, ESCs proliferation was promoted (Fig. 2B) ; however, naive pluripotency genes were greatly down-regulated Growth curves of EB3 ESCs after they were transferred from serum+LIF to serum-free N2B27 medium with or without Activin A or PD0325901. The graph represents mean AE SD (n = 3 independent experiments). (C) qRT-PCR analysis of gene expression levels in EB3 ESCs cultured in N2B27 medium with or without Activin A or PD0325901 for 2 and 4 days. The graph represents mean AE SD (n = 3 independent experiments).
( Fig. 2C) . Thus, Activin A alone is unable to sustain ESCs in an undifferentiated state. Because Activin A acts as a primed pluripotencypromoting factor when it is combined with bFGF which activates the ERK1/2 MAPK pathway, we were interested in the effect of ERK1/2 MAPK pathway inhibition on ESC self-renewal in the presence or absence of Activin A. The addition of the ERK1/2 MAPK pathway inhibitor PD0325901 alone was unable to sustain proliferation and expression of pluripotency genes in ESCs (Fig. 2B,C) . Surprisingly, when both Activin A and PD0325901 were added to the medium, EB3 ESCs continued proliferation, similar to those in 2i (Fig. 3A) . The expression levels of naive pluripotency genes (Klf2 and Esrrb) along with Oct4, Nanog, and Sox2 were maintained in Activin+PD for more than 3 months (Fig. 3B) . The ESCs cultured in Activin+PD tended to form flat morphology, different from ESCs cultured in 2i (Fig. 4A ). OCT4 and NANOG proteins were detected in the nuclei of ESCs cultured in Activin+PD, similar to those cultured in 2i (Fig. 4B) . When ESCs maintained in Activin+PD were subjected to in vitro differentiation protocols, they were able to differentiate into cells of three germ layers, suggesting that they retain differentiation potentials (Fig. 4C) . Like EB3 ESCs, another feeder-free ESC line, CGR8, also can be propagated in Activin+PD (Fig. 3A) . The expression levels of Oct4, Nanog, Sox2, Esrrb, and Klf2 were also maintained in CGR8 cultured in Activin+PD (Fig. 3C ). V6.5 ESCs and Ng-20D-17 iPS cells, which are feeder-dependent cell lines, were also able to propagate in Activin+PD when cultured on feeder layers (Fig. 5A) . Activin+PD failed to support propagation of these two cell lines when cultured without feeder cells (Fig. 5B) . Thus, these observations suggest that Activin A in combination with the ERK1/2 MAPK inhibitor has an ability to promote proliferation of ESCs in an undifferentiated state.
ESCs cultured in Activin+PD show features of the naive pluripotency state As ESCs cultured in Activin+PD showed sustained expression of several naive pluripotency genes, we examined whether ESCs maintained in Activin+PD are in a naive pluripotency state. To assess the global gene expression pattern of ESCs cultured in Activin+PD, we carried out genomewide gene expression analysis in four kinds of samples: EB3 ESCs cultured in 2i, LIF+BMP4, Activin+PD, and EpiSCs.
Clustering analysis showed that ESCs cultured in Activin+PD were close to naive ESCs cultured in 2i and LIF+BMP4 (Fig. 6A) . Scatter plots clearly showed the similarity in the global gene expression pattern between ESCs cultured in Activin+PD and 2i (Fig. 6B) . ESCs cultured in Activin+PD also exhibited positive staining for alkaline phosphatase (AP), similar to ESCs cultured in 2i or 2i+LIF (Fig. 6C) . Consistent with the previous report (Brons et al. 2007 ), EpiSCs did not show AP staining (Fig. 6C) . As the previous report showed a clear difference in the usage of proximal and distal enhancers of Oct4 between naive and primed pluripotency states (Tesar et al. 2007) , we carried out the luciferase reporter assay using the distal and proximal enhancers. The activity of the distal enhancer (DE) was higher than that of the proximal enhancer (PE) in ESCs cultured in Activin+PD or 2i, but the activity of PE was higher than that of DE in EpiSCs (Fig. 6D) . These results indicate the similarity in the cell state between ESCs cultured in Activin+PD and ESCs maintained by 2i culture in the naive pluripotency state.
The naive and primed pluripotent stem cells show different responses to Wnt signaling pathway, as shown in Fig. 1 . Therefore, we examined the response of ESCs cultured in Activin+PD to Wnt signaling pathway activation. When the medium condition was changed from Activin+PD or 2i to CHIR99021, ESCs formed domed colonies and retained the high-level expression of pluripotency genes (Fig. 6E,F) . In contrast, when EpiSCs were treated with CHIR99021, the EpiSC colonies showed diminished cell-cell interaction (Fig. 6E) . Moreover, the expression of mesoderm genes, Tbx6, Mesp1, and FoxC1, was up-regulated and the expression of Oct4 and Nanog was almost completely lost ( Fig. 6F) , indicating mesoderm differentiation. Thus, the self-renewal response of ESCs in Activin+PD to Wnt pathway activation is similar to that of naive pluripotent stem cells. Collectively, these results suggest that the ESCs cultured in Activin+PD are in the state of naive pluripotency. Although ESCs cultured in Activin+PD show similarity to ESCs cultured in 2i, transcriptome analysis shows that some genes were specifically expressed in ESCs cultured in Activin+PD (Table S1 in Supporting Information). Gene ontology analysis showed that 77 genes that were specifically expressed in ESCs cultured in Activin+PD were related to developmental processes, such as sexual reproduction and gamete generation, and tubulin (Fig. 7A) , and that 53 genes that were specifically expressed in ESCs cultured in 2i were related to pattern formation and homeobox (Fig. 7B ). These data show that ESCs cultured in Activin+PD are similar, but not identical, to those cultured in 2i.
Discussion
In this study, we have shown that Activin A, when combined with the ERK1/2 MAPK inhibitor, can sustain proliferation of ESCs which retain naive pluripotency features. This finding broadens our view of the action of Activin/Nodal/TGF-b signaling in the signaling and transcriptional networks in pluripotency. Our analysis showed that the expression of SMAD3 target genes was strongly enriched in ESCs. We then found that Activin A can support selfrenewal of the ESC naive pluripotency state when combined with the ERK1/2 MAPK pathway inhibitor PD0325901. The ESCs cultured in Activin+PD exhibited naive pluripotency features, which include the characteristic genomewide gene expression profile, the preferential usage of the Oct4 distal enhancer, and the self-renewal response to Wnt signaling pathway activation. Although the positive effect of Activin/Nodal/TGF-b signaling on the proliferation of ESCs was reported previously (Ogawa et al. 2007 ), this study is the first to show the ability of Activin A to promote ESC propagation with naive pluripotency features. However, Activin/Nodal/TGF-b signaling pathway inhibition has been reported to enhance mouse iPS cell generation (Ichida et al. 2009; Maherali & Hochedlinger 2009 ). The inhibition of Activin/ Nodal/TGF-b signaling was also shown to enhance efficient maintenance of the naive pluripotency states of mouse refractory strain ESCs and rat ESCs , and AFP (endodermal marker). EB3 ESCs were subjected to in vitro differentiation protocols after 3 weeks of culture in Activin+PD. Scale bars, 100 lm.
Genes to Cells (2017) 22, 189-202 (Kawamata & Ochiya 2010; Hassani et al. 2014 ). These observations imply that Activin/Nodal/TGF-b has both positive and negative effects on naive pluripotency in a context-dependent manner. We hypothesize that Activin/Nodal/TGF-b signaling alone may act positively on the expression of a group of naive pluripotency genes and negatively on the expression of other naive pluripotency genes, and the balance between strength of Activin/Nodal/TGF-b signaling and the activities of other signaling pathways might determine the output. Several culture protocols to propagate human ESCs with naive pluripotency features have been reported, and they all require the inclusion of Activin A/TGF-b Gafni et al. 2013; Theunissen et al. 2014; Ware et al. 2014) . Our finding that Activin signaling activation can promote ESC naive pluripotency gene expression might account for the need of Activin A/TGF-b for human naive pluripotency culture protocols. SMAD2/3 are known to interact with various transcription factors, such as FOXH1, OCT4, NANOG, and BRACHYURY, which mediate diverse responses of pluripotent stem cells to Activin/ Nodal/TGF-b signaling (Labb e et al. 1998; Vallier et al. 2009; Mullen et al. 2011; Beyer et al. 2013b; Faial et al. 2015) . We can assume the existence of naive pluripotency state-specific transcription factors, which cooperate with SMAD2/3 to promote naive pluripotency. How the interactions of SMAD2/3 with other transcription factors and signaling pathways elicit context-dependent responses in pluripotent stem cells will be investigated in future studies.
Experimental procedures
Cell culture EB3 ESCs (Niwa et al. 2002; Ogawa et al. 2004 ; an E14tg2a derivative purchased from Riken Cell Bank) were used for most of the experiments. CGR8 (kindly provided by Dr. Hitoshi Niwa) and V6.5 ESC lines and an iPS cell line (iPS-MEF-Ng-20D-17; Okita et al. 2007 ) were analyzed for their proliferation shown in Figs 3A and S2.
ESCs were cultured on 0.1% gelatin-coated dishes. The culture medium for EB3 ESCs is composed of GMEM (Wako or Gibco), 10% FCS (Hyclone murine embryonic stem cell screened; Thermo), 1 mM nonessential amino acid (Gibco), 1 mM sodium pyruvate (Sigma), 0.1 mM b-mercaptoethanol (Gibco), and 1000 unit/mL LIF (Millipore). The culture medium for CGR8 ESCs carrying IRES-HyTk in one of Oct-3/4 locus is composed of DMEM (Nacalai Tesque), 15% FCS (Hyclone murine embryonic stem cell screened; Thermo), 1 mM nonessential amino acid (Gibco), 1 mM sodium pyruvate (Sigma), 1% Embryo Max 1009 nucleosides (Millipore), 2 mM L-glutamine (GIBCO), 0.1 mM b-mercaptoethanol (Gibco), and 1000 unit/mL LIF (Millipore). V6.5 ESCs and an iPS cell line iPS-MEF-Ng-20D-17 were maintained in 2i+LIF. For serum-free culture, ESCs were cultured on 0.1% gelatin-coated CellBIND surface dishes (Corning) in N2B27 supplemented with growth factors and inhibitors indicated in each experiment. The N2B27 medium is composed of DMEM/F12 (Wako or Gibco), 0.5 9 N2 supplement (Wako or Gibco), 0.5 9 B27 supplement (Gibco), 50 lg/mL BSA (Gibco), and 0.1 mM bmercaptoethanol (Gibco). EpiSCs were induced from EB3 ESCs (Guo et al. 2009 ), by culturing them in N2B27 supplemented with 20 ng/mL Activin A (R&D or Peprotech) and 12 ng/mL bFGF (R&D) on dishes coated with serum for more than 3 weeks. For experiments comparing ESCs and EpiSCs in Fig. 1 , ESCs were cultured in N2B27 + LIF+BMP4 (Ying et al. 2003) . The concentrations of Activin A and chemical inhibitors Genes to Cells (2017) 22, 189-202 used for serum-free culture of ESCs were 20 ng/mL for Activin A (R&D or Peprotech), 2 lM for CHIR99021 (Axon), and 2 lM for PD0325901 (Wako) unless otherwise specified. HEK293T cells were cultured in DMEM containing 10% FCS.
In vitro differentiation of ESCs
For differentiation to neurons, ESCs cultured in Activin+PD were dissociated by Accutase and cultured on bacterial dishes in N2B27 to allow formation of embryoid bodies. Five days later, the embryoid bodies were plated onto L-ornithine and fibronectin-coated coverslips. After 4 days, cells were fixed. For differentiation to cardiomyocytes, ESCs from Activin+PD were cultured in the serum-containing ESC medium without LIF in hanging-drop culture of 8 9 10 2 cells. Two days later, the embryoid bodies were transferred to bacterial dishes. Five days later, the embryoid bodies were plated onto gelatin-coated coverslips. After 4 days, cells were fixed. For endoderm differentiation, ESCs cultured in Activin+PD were dissociated by Accutase and cultured in bacterial dishes in N2B27. Two days later, the embryoid bodies were dissociated by Accutase and cultured in bacterial dishes in N2B27 supplemented with 20 ng/ml Activin A. Three days later, the embryoid bodies were plated onto gelatin-coated coverslips. After 4 days, cells were fixed. 
Immunostaining
Cells were fixed with 4% PFA in PBS for 15 min at room temperature. Then, the cells were permeabilized with 0.5% Triton X-100 and blocked with 3% BSA in PBS. Then, cells were incubated with primary antibodies overnight at 4°C. Next, cells were incubated with fluorescently labeled secondary antibodies (Molecular Probes) for 1 h at room temperature. Primary antibodies used were anti-OCT3/4 (1:200, Santa Cruz Biotechnology, sc-5279), anti-NANOG (1:1000, Calbiochem, SC-1000), anti-TUJ1 (1:250, Sigma), anti-cTnT (1:200, Thermo, MS-295), and anti-AFP (1:400, DAKO, A000829).
Alkaline phosphatase staining
Alkaline phosphatase staining was carried out with the leukocyte alkaline phosphatase kit (Sigma) according to the manufacturer's protocol.
Microarray analysis
For the microarray experiment in Fig. 1 , ESCs cultured in LIF+BMP4 and EpiLCs were treated with 3 lM CHIR99021 or 3 lM CHIR99021 + 1 lM PD0325901 for 24 h and harvested. The microarray data for ESCs cultured in LIF+BMP4 in Fig. 1 are also analyzed in Fig. 4 . For the microarray experiment in Fig. 4 , ESCs cultured in Activin+PD for 64 days, ESCs cultured in 2i for 34 days, and EpiSCs were harvested for RNA isolation. Total RNA was isolated with RNeasy Mini kit (Invitrogen). During the isolation, on-column DNase I digestion was carried out. Biotinylated sense-strand DNA was synthesized with GeneChip WT PLUS Reagent kit (Affymetrix), hybridized to Mouse Gene 2.0 ST Array (Affymetrix), and analyzed by GeneChip Scanner 7G System (Affymetrix). The data were analyzed by GENESPRINGGX11.5 software (Agilent) and programming software R. The GO analysis was conducted by DAVID (da Huang et al. 2009a, b) . The microarray data have been deposited at NCBI GEO under accession numbers GSE74963 and GSE84679.
Luciferase assay
The distal and proximal enhancers of Oct4 were amplified from ESC genomic DNA. Primers for amplification are the same as in the previous report (Tesar et al. 2007 ). Oct4 enhancers were inserted into pGL3-promoter vector. The 3 0 enhancer sequence of Mesp1 conserved among species was obtained by VISTA program (Frazer et al. 2004) . The 3 0 Mesp1 enhancer sequence was amplified from ESC genomic DNA and inserted into pGL4.10 vector with minimal promoter. For the assay of Oct4 enhancer, 1 day after seeding cells in 35-mm dish, equal amounts of pGL3-promoter vector with or without Oct4 enhancers and pGL4.74 vector for control were transfected into cells with Lipofectamine 2000 (Invitrogen). Thirty hours after transfection, cells were harvested. For the assay of Mesp1 enhancer, equal amounts of pGL4.10 vector with or without Mesp1 enhancers and an expression vector for DN-b-catenin and pGL4.74 vector for control were transfected into cells with FuGENE HD (Promega). Forty-eight hours after transfection, cells were harvested. Assays were carried out with the DualLuciferase Reporter Assay System (Promega). Signals were detected using GloMax Multi + Detection System (Promega).
